Development and validation of targeted treatments for the rare tumor syndrome infantile myofibromatosis.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.15_suppl.e22519
Abstract: e22519Background: Infantile myofibromatosis (IMF; MIM 228550) is an autosomal dominant disorder characterized by fibroblastic tumors of skin, muscles, viscera and bones. Tumor growth may begin duri... read more here.
Keywords: validation targeted; development validation; infantile myofibromatosis; treatments rare ... See more keywords